Sector research & bespoke advisory
Bioindustry.
Health & Nutrition.
A bespoke, independent, operator-led practice across two lenses: Bioindustry & Bio-based Economy, where the work is process and scale; and Health & Nutrition, where it is product and health science. It comes from inside the industry — research that takes a clear position and shows how it got there; advisory shaped to the decision in front of you.
Three ways to work together.
Sector Research
Reports and investor briefs on sectors I know from the inside. Each edition carries a named forward call backed by sourced numbers.
Browse catalogue →Strategic Advisory
Your options through every lens that matters — customer, market, technology, IP, and where the science is heading. Sector diligence, competitive and IP landscapes, regulatory strategy, partner identification. Bespoke, confidential, scoped to your decision.
Service lines →BD & Dealmaking Advisory
Licensing, partnerships, and M&A advice for founders and corporates. Two decades of dealmaking across every direction.
How we work →Two lenses.
One practice, two ways of seeing it. The first is process-led — using industrial biosciences to make production more sustainable and more competitive, whatever the end market. The second is product-led — the science behind a health benefit, and the value proposition it carries to the consumer.
Bioindustry & Bio-based Economy
Process- and scale-focused. Large-scale fermentation, raw material flows, biorefining, supply chain.
- Industrial enzymes
- Precision fermentation & synthetic biology
- Classic fermentation
- Sustainable raw materials
Health & Nutrition
Product- and health-science focused. Claims & substantiation. Brand strategy.
- Specialty bio-ingredients (HMOs, prebiotics, sweeteners)
- Pre/pro/postbiotics — supplements
- Pre/pro/postbiotics — skin microbiome
- Functional foods & claims
How we work
Insight that desk research cannot produce.
This is research and advice from someone who has run the companies and structured the deals. SUDEVCO publishes only in sectors where that operating experience and a warm network produce a read the desk cannot — the catalogue stays small on purpose, and the advisory work is its natural extension.
Start a conversation →-
From inside the industry
Two decades running companies and structuring deals across DuPont Industrial Biosciences, Inbiose, and S-Biomedic — not a literature review.
-
Sourced, then pressure-tested
Primary sources triangulated against live industry conversation, in sectors with a real track record — never automated desk research.
-
A named forward call
Every edition ends on a clear forward call with our name on it — a view specific enough to plan against.